Skip to main content

Payer Perspectives in Dermatology

Payers' Perspectives
Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea
Lisa A. Raedler, PhD, RPh
Read More
Combating Antibiotic Resistance a National Priority Reinforced by a New Executive Order
Dana Butler
Read More
The Impact of Rosacea and Acne on a Patient’s Quality of Life Is Comparable to Other Chronic Conditions
Laura Morgan
Read More
Rosacea
Novel Rosacea Compound, Ivermectin Cream, Offers Unique Mechanism of Action
Caroline Helwick
Read More
Rosacea
Ivermectin Cream Will Contribute Much to the Treatment of Patients with Rosacea: Interview with Dr Zoe Draelos
Caroline Helwick
Read More
Rosacea
Addressing an Unmet Need in the Treatment of Patients with Papulopustular Rosacea: An Interview with Dr Linda Stein Gold
Caroline Helwick
Read More
Rosacea
Investigational Agent Clears Papulopustular Rosacea by Tackling an Underlying Cause
Caroline Helwick
Read More
Rosacea
The Social Impact of Rosacea, Patterns of Care, and Associated Costs Featured at AAD 2014
Caroline Helwick
Read More
Rosacea
AAD 2014 Highlights: Understanding Inflammation Markers and Treating Erythema in Rosacea
Caroline Helwick
Read More
Rosacea: A Multifaceted Skin Disorder
Caroline Helwick
Read More
Page 1 of 3
Results 1 - 10 of 25